TOXICS RELEASE INVENTORY List of Toxic Chemicals within Warfarin Category
Section 313 of EPCRA requires certain facilities manufacturing, processing, or
otherwise using listed toxic chemicals to report their environmental releases of such chemicalsannually. Beginning with the 1991 reporting year, such facilities also must report pollutionprevention and recycling data for such chemicals, pursuant to section 6607 of the PollutionPrevention Act, 42 U.S.C. 13106. When enacted, section 313 established an initial list oftoxic chemicals that was comprised of more than 300 chemicals and 20 chemical categories. Section 313(d) authorizes EPA to add chemicals to or delete chemicals from the list, and setsforth criteria for these actions. CONTENTS Section 1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Section 2. CAS Number List of Chemicals within the Warfarin Category . . . 4 Section 3. CAS Number List of Mixtures Within the Warfarin Category . . . 5 Section 1. Introduction
On November 30, 1993 EPA added 21 chemicals and 2 categories to the list of toxic
chemicals under section 313 of the Emergency Planning and Community Right-to-Know Actof 1986 (EPCRA) (58 FR 63500). These additions are described at 40 CFR 372.65, and areeffective January 1, 1994 for reports due July 1995. Two chemical categories(ethylenebisdithiocarbamic acid (EBDC), salts and esters; warfarin and salts) are included inthese additions. At the time of the addition, EPA indicated that the Agency would work withthe public and the regulated community to develop, as appropriate, interpretations andguidance the Agency determines are necessary to facilitate accurate reporting for thesecategories. This document constitutes such guidance for warfarin and salts.
EPCRA section 313 requires threshold determinations for chemical categories to be
based on the total of all chemicals in the category manufactured, processed, or otherwise used. For example, a facility that manufactures three members of a chemical category would countthe total amount of all three chemicals manufactured towards the manufacturing threshold forthat category. When filing reports for chemical categories, the releases are determined in thesame manner as the thresholds. One report is filed for the category and all releases arereported on this form.
The warfarin salts category is subject to the one percent de minimis concentration.
Thus, mixtures that contain members of these categories equal to or in excess of the deminimis should be factored into threshold and release determinations.
Any compound which has a warfarin salt component is reportable. EPA is providing
the following list of CAS numbers and chemical names to aid the regulated community indetermining whether they need to report the Warfarin category. However, this list is notexhaustive. If a facility is manufacturing, processing, or using a chemical which has awarfarin salt component, they must report to TRI, even if this chemical does not appear on thefollowing list. Who Must Report
A plant, factory, or other facility is subject to the provisions of Section 313, if it meets
It is included in a covered Standard Industrial Classification (SIC) code as listedin the following table; and
4911, 4931, and 4939, limited to facilities that combust coaland/or oil for the purpose of generating electricity fordistribution in commerce
Treatment, Storage, and Disposal facilities
4953, limited to RCRA Subtitle C permitted or interim statusfacilities
7389, limited to facilities primarily engaged in solventrecovery services on a contract or fee basis
It has 10 or more full-time employees (or the equivalent 20,000 hours per year);and
It manufacturers, imports, processes, or otherwise uses any of the toxicchemicals listed on the EPCRA Section 313 list in amounts greater than the"threshold" quantities specified below.
Thresholds
Thresholds are specified amounts of toxic chemicals used during the calendar year that
If you manufacture or import any of the listed toxic chemicals, the threshold quantity
25,000 pounds per toxic chemical or category over the calendar year.
If you process any of the listed toxic chemicals, the threshold quantity will be:
25,000 pounds per toxic chemical or category over the calendar year.
If you otherwise use any of the listed toxic chemicals (without incorporating it into any
product or producing it at the facility), the threshold quantity is:
10,000 pounds per toxic chemical or category over the calendar year. Section 2. CAS Number List of Chemicals that have CAS numbers within the Warfarin Category
EPA is providing the following list of CAS numbers and chemical names to aid the
regulated community in determining whether they need to report for the Warfarin category. However, this list is not exhaustive. If a facility is manufacturing, processing, or using achemical which has a Warfarin component, they must report to TRI, even if this chemical doesnot appear on the following list. Listing by CAS Number of Each Individual Chemical within the Warfarin and Salts Category Collective Index Name Common Name
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, sodium salt
Coumarin, 3-(.alpha.-acetonylbenzyl)-4-hydroxy-, calcium salt
Coumarin, 3-(.alpha.-acetonylbenzyl)-4-hydroxy-, magnesium salt
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, potassium salt
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, lithium salt
2H-1-benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, sodium salt, (S)-
2H-1Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, sodium salt, (R)-
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, sodium salt, (.+-.)-
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, thallium(1+) salt
* - Indicates the mixtures under this category
Section 3. CAS Number List of Mixtures Within the Warfarin Category
EPA is providing the following list of CAS numbers and chemical names for mixtures
which contain Warfarin and its salts. This list will aid the regulated community in determiningwhether they need to report for the Warfarin category. However, this list is not exhaustive. Ifa facility is manufacturing, processing, or using a mixture that contains Warfarin or aWarfarin salt component, they must report to TRI, even if this chemical does not appear on thefollowing list. Threshold calculations for the Warfarin category should account only for thepercentage of the Warfarin component contained in the mixture. Mixtures Containing Warfarin and its Salts Mixture Name Warfarin Mixture CAS Component
Benzenesulfonamide, 4-amino-N-2-quinoxalinyl-, mixt. with
4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, sodium salt, mixt. with acetaldehyde, 2-butanone,
N,N-dimethylmethanamine, formaldehyde, .alpha.-hydro-.omega.-hydroxypoly(oxy-1,2-ethanediyl),
4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one sodium salt and 2,2',2''-nitrilotris[ethanol]
9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol, (3.beta.,5Z,7E,22E)-, mixt. with
4-hydroxy-3-(3-oxo-1-phenylbutyl)- 2H-1-benzopyran-2-one
1H-Indene-1,3(2H)-dione, 2-(2,2-dimethyl-1-oxopropyl)-, mixt. with
4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
Benzenesulfonamide, N-[(butylamino)carbonyl]-4-methyl-, mixt. with
4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
Retinol, acetate, mixt. with 4-hydroxy-3-(3-oxo-1-phenylbutyl)- 2H-1-benzopyran-2-one12
Antimycin A, mixt. with 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1- benzopyran-2-one
1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, mixt. with
4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (S)-, mixt. with
4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide, mixt. with
4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H- 1-benzopyran-2-one
2H,5H-1,3-Oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione, 5-methyl-3-(2-pyridinyl)-, 6,6-dioxide,
mixt. with 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
Benzoic acid, 2-(acetyloxy)-, mixt. with 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, mixt. with
4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
Mixtures Containing Warfarin and its Salts Mixture Name Warfarin Mixture CAS Component
3,5-Pyrazolidinedione,1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-, mixt. with
4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, mixt. with 5-[(2-chlorophenyl)methyl]-
ABSTRACTS EXPLORING EMOTIONAL EXPERIENCES IN THE CLASSROOM: A MULTI- METHOD QUALITATIVE STUDY Wondimu Ahmed ABSTRACT The purposes of this study were two-fold: (a) to explore students’ emotional experiences in the classroom; (b) to examine how appraisals of self-competence and task value relate to these emotions. To attain this purpose six junior secondary students were recr
News, Data and Business Strategies for Health Plans, Employers, PBMs and Pharma CompaniesHouse Passes Part D Rx Negotiations Bill;As expected, the full House passed legislation last week that gives HHS the au-thority to negotiate prescription drug prices under the Medicare Part D benefit. Theinitiative, however, is expected to face a much tougher time in the Senate, where someDemocrats alre